Department of Gastric Surgery, Fujian Medical University Union Hospital, Fuzhou, China.
Fujian Key Laboratory of Tumor Microbiology, Fujian Medical University, Fuzhou, China.
Surg Endosc. 2022 Nov;36(11):8639-8650. doi: 10.1007/s00464-022-09352-1. Epub 2022 Jun 13.
Robotic surgery may be advantageous for complex surgery. We aimed to compare the intraoperative and postoperative short-term outcomes of spleen-preserving splenic hilar lymphadenectomy (SPSHL) during robotic and laparoscopic total gastrectomy.
From July 2016 to December 2020, the clinicopathological data of 115 patients who underwent robotic total gastrectomy combined with robotic SPSHL (RSPSHL) and 697 patients who underwent laparoscopic total gastrectomy combined with laparoscopic SPSHL (LSPSHL) were retrospectively analyzed. A 1:2 ratio propensity score matching (PSM) was used to balance the differences between the two groups to compare their outcomes. The Generic Error Rating Tool was used to evaluate the technical performance.
After PSM, the baseline preoperative characteristics of the 115 patients in the RSPSHL and 230 patients in the LSPSHL groups were balanced. The dissection time of the region of the splenic artery trunk (5.4 ± 1.9 min vs. 7.8 ± 3.6 min, P < 0.001), the estimated blood loss during SPSHL (9.6 ± 4.8 ml vs. 14.9 ± 7.8 ml, P < 0.001), and the average number of intraoperative technical errors during SPSHL (15.1 ± 3.4 times/case vs. 20.7 ± 4.3 times/case, P < 0.001) were significantly lower in the RSPSHL group than in the LSPSHL group. The RSPSHL group showed higher dissection rates of No. 10 (78.3% vs. 70.0%, P = 0.104) and No. 11d (54.8% vs. 40.4%, P = 0.012) lymph nodes and significantly improved postoperative recovery results in terms of times to ambulation, first flatus, and first intake (P < 0.05). The splenectomy rates of the two groups were similar (1.7% vs. 0.4%, P = 0.539), and there was no significant difference in morbidity and mortality within postoperative 30 days (13.0% vs. 15.2%, P = 0.589).
Compared to LSPSHL, RSPSHL has more advantages in terms of surgical qualities and postoperative recovery process with similar morbidity and mortality. For complex SPSHL, robotic surgery may be a better choice.
机器人手术可能对复杂手术有益。我们旨在比较机器人辅助保留脾脏的脾门淋巴结清扫术(RSPSHL)与腹腔镜辅助保留脾脏的脾门淋巴结清扫术(LSPSHL)在机器人全胃切除术中的术中及术后短期结果。
从 2016 年 7 月至 2020 年 12 月,回顾性分析了 115 例行机器人全胃切除术联合 RSPSHL 和 697 例行腹腔镜全胃切除术联合 LSPSHL 的患者的临床病理资料。采用 1:2 比例倾向评分匹配(PSM)来平衡两组间的差异,以比较其结果。采用通用错误评分工具(Generic Error Rating Tool)评估技术性能。
PSM 后,RSPSHL 组 115 例和 LSPSHL 组 230 例患者的基线术前特征平衡。脾动脉干区域的解剖时间(5.4±1.9 min 比 7.8±3.6 min,P<0.001)、SPSHL 时的估计出血量(9.6±4.8 ml 比 14.9±7.8 ml,P<0.001)和 SPSHL 时的平均术中技术错误数(15.1±3.4 次/例比 20.7±4.3 次/例,P<0.001)均显著低于 LSPSHL 组。RSPSHL 组在 No.10(78.3%比 70.0%,P=0.104)和 No.11d(54.8%比 40.4%,P=0.012)淋巴结的清扫率更高,术后恢复时间(下床活动、首次排气和首次进食)也得到了显著改善(P<0.05)。两组的脾切除术率相似(1.7%比 0.4%,P=0.539),术后 30 天内的发病率和死亡率无显著差异(13.0%比 15.2%,P=0.589)。
与 LSPSHL 相比,RSPSHL 在手术质量和术后恢复过程方面具有更多优势,且发病率和死亡率相似。对于复杂的 SPSHL,机器人手术可能是更好的选择。